EUVIMEDEUVIMED entdecken
Crossref

Toward Personalized Surgery in Advanced Prostate Cancer: Stratification by PTEN, AR-V7, TP53, TMPRSS2-ERG, and ERBB2 Genetic Alterations

Cristina Anita Ionescu, Georgeta Camelia Cozaru, Mariana Aşchie, Nicoleta Leopa, Bogdan Cîmpineanu, Felix Voinea, Elena Matei, Anca Mitroi, Mariana Deacu, Ionuţ Iorga, Mihaela Pundiche

Chirurgia · 2025

DOI: 10.21614/chirurgia.3151 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chirurgia, 2025. Verfasst von Cristina Anita Ionescu und 10 weiteren Autor:innen. Hauptthemen laut MEDLINE: Prostatic Neoplasms, PTEN Phosphohydrolase, Prostatectomy, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Advanced prostate cancer is a biologically heterogeneous disease often marked by multiple genetic and epigenetic alterations that influence tumor progression, treatment resistance, and prognosis. Among the most frequently altered genes are PTEN, AR-V7, TP53, TMPRSS2-ERG, and ERBB2, each with potential relevance for stratifying risk and guiding targeted therapy.

Methods

This retrospective study included 43 patients with advanced prostate cancer who underwent radical prostatectomy. Tumor specimens were analyzed using fluorescence in situ hybridization (FISH) to assess the mutational status of the five markers. Clinicopathological parameters, including PSA levels, Gleason score, tumor stage, and invasion status, were correlated with molecular alterations using multinomial logistic regression.

Results

The most common isolated alteration was PTEN loss (20.9%), followed by TP53 amplification (16.3%), TMPRSS2-ERG fusion (13.9%), AR-V7 expression (11.6%), and ERBB2 amplification (7%). Combined alterations were also observed, with dual or triple marker expression in select aggressive cases. PTEN- and AR-V7+ were associated with low PSA values despite aggressive pathology, while ERBB2+ correlated with high PSA levels and high Gleason scores. TP53+ and ERBB2+ were also significantly associated with high-grade tumors (Gleason 7). AR-V7+ was the only marker significantly associated with seminal vesicle invasion. Younger age was weakly correlated with AR-V7+ and TP53+ status.

Conclusions

The molecular profile defined by PTEN, AR-V7, TP53, and ERBB2 identifies distinct biological subtypes in advanced prostate cancer, each with specific prognostic and therapeutic implications. Integration of these biomarkers into routine clinical assessment may improve treatment personalization and risk stratification. Validation in larger, prospective cohorts is warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsPTEN PhosphohydrolaseProstatectomyBiomarkers, TumorTumor Suppressor Protein p53Erb-b2 Receptor Tyrosine KinasesPrecision MedicineHumansMaleRetrospective StudiesMiddle AgedAgedOncogene Proteins, FusionNeoplasm GradingIn Situ Hybridization, FluorescenceTreatment OutcomePrognosisNeoplasm StagingRisk AssessmentMutation

Stichwörter der Autor:innen

biomarkersgeneticprofilepersonalizedsurgeryprognosisprostatecancer

Substanzen

PTEN PhosphohydrolaseBiomarkers, TumorTumor Suppressor Protein p53Erb-b2 Receptor Tyrosine KinasesOncogene Proteins, FusionPTEN protein, humanERBB2 protein, humanTMPRSS2-ERG fusion protein, humanTP53 protein, human

Zitieren

APA

Ionescu, C. A., Cozaru, G. C., Aşchie, M., Leopa, N., Cîmpineanu, B., Voinea, F., Matei, E., Mitroi, A., Deacu, M., Iorga, I., & Pundiche, M. (2025). Toward Personalized Surgery in Advanced Prostate Cancer: Stratification by PTEN, AR-V7, TP53, TMPRSS2-ERG, and ERBB2 Genetic Alterations. Chirurgia. https://doi.org/10.21614/chirurgia.3151

Vancouver

Ionescu CA, Cozaru GC, Aşchie M, Leopa N, Cîmpineanu B, Voinea F, et al. Toward Personalized Surgery in Advanced Prostate Cancer: Stratification by PTEN, AR-V7, TP53, TMPRSS2-ERG, and ERBB2 Genetic Alterations. Chirurgia. 2025. doi:10.21614/chirurgia.3151

BibTeX
@article{Ionescu2025,
  author = {Ionescu, Cristina Anita and Cozaru, Georgeta Camelia and Aşchie, Mariana and Leopa, Nicoleta and Cîmpineanu, Bogdan and Voinea, Felix and Matei, Elena and Mitroi, Anca and Deacu, Mariana and Iorga, Ionuţ and Pundiche, Mihaela},
  title = {Toward Personalized Surgery in Advanced Prostate Cancer: Stratification by PTEN, AR-V7, TP53, TMPRSS2-ERG, and ERBB2 Genetic Alterations},
  journal = {Chirurgia},
  year = {2025},
  doi = {10.21614/chirurgia.3151}
}
Kostenlos starten →